Riccardo Lencioni, MD, recently joined the University of Miami Miller School of Medicine as director of interventional oncology research. Here he discusses the University of Miami interventional radiology team and the multidisciplinary team of cancer clinicians who craft individualized treatment… Read More
Interventional locoregional treatments play a key role in the management of hepatocellular carcinoma (HCC). Image-guided percutaneous ablation is recommended in patients with early-stage HCC when surgical options are precluded and can replace resection in selected patients with very early tumors.… Read More
MARLBOROUGH, Mass., Nov. 10, 2015 /PRNewswire/ -- Boston Scientific has entered into a definitive agreement to acquire the interventional radiology portfolio of CeloNova Biosciences, a San Antonio-based developer of endovascular and interventional cardiology technologies. The structured agreement… Read More
Related: Dr. John Haaga Describes Studying Tumor Vessel Formation to Enhance Cancer Care NATIONAL HARBOR, Md. and REDWOOD CITY, Calif., Nov. 07, 2015 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals Inc. (NASDAQ:OMED), a clinical-stage company developing novel anti-cancer stem cell and immuno-… Read More
By Jennifer FordOn November 6, 2015, the second day of the 2015 Synergy interventional oncology meeting in Miami began with a hands-on ablation workshop. The workshop was packed with attendees, many of whom were residents and fellows who earned scholarships for the meeting. Attendees were able to… Read More
By Jennifer FordOn November 5, 2015, the Synergy 2015 meeting had a successful start, celebrating 5 years of a multidisciplinary approach to interventional cancer care. The meeting welcomed nearly 500 registrants to Miami for this year’s event. Day 1, or “PAE Day,” focused on prostate interventions… Read More
VILLEPINTE, France, October 29, 2015 /PRNewswire/ -- Guerbet (GBT) announced today the signing of an agreement with Beijing Kyuan Pharmaceutical Co., Ltd., one of the major pharmaceutical drugs distributors & importers in the Chinese market, to distribute and commercialize Lipiodol Ultra-Fluid… Read More
The Melanoma Research Alliance (MRA) welcomes another exciting new chapter in the treatment of melanoma with the news that the US Food & Drug Administration (FDA) has given approval to Amgen’s immunotherapy drug, IMLYGIC, known as T-VEC for talimogene laherparepvec, for the local treatment of… Read More
Abstract: Transarterial chemoembolization (TACE) plays an important role in the treatment of hepatocellular carcinoma (HCC). Recognition of the tumor arterial supply is necessary to perform effective TACE. In this sense cone-beam computed tomography (CBCT) may be a helpful tool to assist… Read More
ALBANY, N.Y., Oct. 15, 2015 (GLOBE NEWSWIRE) -- AngioDynamics, a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that the NanoKnife System has been approved by South Korea’s Ministry of Food… Read More